The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review
Open accessAbstract
Objectives: Overdiagnosis, the detection through screening of a breast cancer that would never have been identified in the lifetime of the woman, is an adverse outcome of screening. We aimed to determine an estimate range for overdiagnosis of breast cancer in European mammographic service screening programmes. Methods: We conducted a literature review of observational studies that provided estimates of breast cancer overdiagnosis in European population-based mammographic screening programmes. Studies were classified according to the presence and the type of adjustment for breast cancer risk (data, model and covariates used), and for lead time (statistical adjustment or compensatory drop). We expressed estimates of overdiagnosis from each study as a percentage of the expected incidence in the absence of screening, even if the variability in the age range of the denominator could not be removed. Estimates including carcinoma in situ were considered when available. Results: There were 13 primary studies reporting 16 estimates of overdiagnosis in seven European countries (the Netherlands, Italy, Norway, Sweden, Denmark, UK and Spain). Unadjusted estimates ranged from 0% to 54%. Reported estimates adjusted for breast cancer risk and lead time were 2.8% in the Netherlands, 4.6% and 1.0% in Italy, 7.0% in Denmark and 10% and 3.3% in England and Wales. Conclusions: The most plausible estimates of overdiagnosis range from 1% to 10%. Substantially higher estimates of overdiagnosis reported in the literature are due to the lack of adjustment for breast cancer risk and/or lead time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,599
Effect of Screening Mammography on Breast-Cancer Mortality in Norway
Kalager, M., Zelen, M., Langmark, F., & Adami, H.-O. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000727 · Cited by 526
Jorgensen, K. J., & Gotzsche, P. C. (2009) · BMJ · doi:10.1136/bmj.b2587 · Cited by 502
Zackrisson, S., Andersson, I., Janzon, L., Manjer, J., & Garne, J. P. (2006) · BMJ · doi:10.1136/bmj.38764.572569.7c · Cited by 341
Day, N. E., & Walter, S. D. (1984) · Biometrics · doi:10.2307/2530739 · Cited by 263
Duffy, S. W., Tabar, L., Olsen, A. H., Vitak, B., Allgood, P. C., Chen, T. H. H., Yen, A. M. F., & Smith, R. A. (2010) · Journal of Medical Screening · doi:10.1258/jms.2009.009094 · Cited by 240
Self-citationBiesheuvel, C., Barratt, A., Howard, K., Houssami, N., & Irwig, L. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70380-7 · Cited by 196
Interpreting Overdiagnosis Estimates in Population-based Mammography Screening
de Gelder, R., Heijnsdijk, E. A. M., van Ravesteyn, N. T., Fracheboud, J., Draisma, G., & de Koning, H. J. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxr009 · Cited by 185
Self-citationBreast screening: the facts--or maybe not
Gotzsche, P. C., Hartling, O. J., Nielsen, M. B., Brodersen, J., & Jørgensen, K. J. (2009) · BMJ · doi:10.1136/bmj.b86 · Cited by 182
Estimates of overdiagnosis of invasive breast cancer associated with screening mammography
Morrell, S. L., Barratt, A. L., Irwig, L., Howard, K., Biesheuvel, C., & Armstrong, B. K. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9459-z · Cited by 123
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
The benefits and harms of breast cancer screening: an independent review
(2012) · The Lancet · doi:10.1016/s0140-6736(12)61611-0 · Cited by 1,492
Screening, T. I. U. P. O. B. C., Marmot, M. G., Altman, D. G., Cameron, D. A., Dewar, J. A., Thompson, S. G., & Wilcox, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.177 · Cited by 1,069
Overdiagnosis and Overtreatment of Prostate Cancer
Loeb, S., Bjurlin, M. A., Nicholson, J., Tammela, T. L., Penson, D. F., Carter, H. B., Carroll, P., & Etzioni, R. (2014) · European Urology · doi:10.1016/j.eururo.2013.12.062 · Cited by 964
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., & Straif, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 962
International Variation in Female Breast Cancer Incidence and Mortality Rates
DeSantis, C. E., Bray, F., Ferlay, J., Lortet-Tieulent, J., Anderson, B. O., & Jemal, A. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0535 · Cited by 804
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., Brawley, O. W., & Wender, R. C. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21392 · Cited by 719
Benefits and Harms of Breast Cancer Screening: A Systematic Review
Myers, E. R., Moorman, P., Gierisch, J. M., Havrilesky, L. J., Grimm, L. J., Ghate, S., Davidson, B., Mongtomery, R. C., Crowley, M. J., McCrory, D. C., et al. (2015) · JAMA · doi:10.1001/jama.2015.13183 · Cited by 637
Arnold, M., Karim-Kos, H. E., Coebergh, J. W., Byrnes, G., Antilla, A., Ferlay, J., Renehan, A. G., Forman, D., & Soerjomataram, I. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2013.09.002 · Cited by 513
Smith, R. A., Manassaram-Baptiste, D., Brooks, D., Cokkinides, V., Doroshenk, M., Saslow, D., Wender, R. C., & Brawley, O. W. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21212 · Cited by 478
A Systematic Assessment of Benefits and Risks to Guide Breast Cancer Screening Decisions
Pace, L. E., & Keating, N. L. (2014) · JAMA · doi:10.1001/jama.2014.1398 · Cited by 461
Quaresma, M., Coleman, M. P., & Rachet, B. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61396-9 · Cited by 461
Comstock, C. E., Gatsonis, C., Newstead, G. M., Snyder, B. S., Gareen, I. F., Bergin, J. T., Rahbar, H., Sung, J. S., Jacobs, C., Harvey, J. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.0572 · Cited by 456
Smith, R. A., Manassaram‐Baptiste, D., Brooks, D., Doroshenk, M., Fedewa, S., Saslow, D., Brawley, O. W., & Wender, R. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21261 · Cited by 451
Smith, R. A., Brooks, D., Cokkinides, V., Saslow, D., & Brawley, O. W. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21174 · Cited by 422
Nelson, H. D., Pappas, M., Cantor, A., Griffin, J., Daeges, M., & Humphrey, L. (2016) · Annals of Internal Medicine · doi:10.7326/m15-0970 · Cited by 410
Benefits and harms of mammography screening
Løberg, M., Lousdal, M. L., Bretthauer, M., & Kalager, M. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0525-z · Cited by 368
Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer
Kuhl, C. K., Strobel, K., Bieling, H., Leutner, C., Schild, H. H., & Schrading, S. (2017) · Radiology · doi:10.1148/radiol.2016161444 · Cited by 350
Screening for lung cancer: 2023 guideline update from the American Cancer Society
Wolf, A. M. D., Oeffinger, K. C., Shih, T. Y., Walter, L. C., Church, T. R., Fontham, E. T. H., Elkin, E. B., Etzioni, R. D., Guerra, C. E., Perkins, R. B., et al. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21811 · Cited by 310
Screening for Breast Cancer in 2018—What Should We be Doing Today?
Seely, J. M., & Alhassan, T. (2018) · Current Oncology · doi:10.3747/co.25.3770 · Cited by 258
Kempt, H., & Nagel, S. K. (2022) · Journal of Medical Ethics · doi:10.1136/medethics-2021-107440 · Cited by 87
The economics of diagnostic safety
Slawomirski, L., Kelly, D., de Bienassis, K., Kallas, K.-A., & Klazinga, N. (2025) · OECD Health Working Papers · doi:10.1787/fc61057a-en · Cited by 20
Metadata
- Authors
- Puliti, D., Duffy, S. W., Miccinesi, G., De Koning, H., Lynge, E., Zappa, M., & Paci, E.
- Venue
- Journal of Medical Screening
- Publisher
- SAGE Publications
- Published
- 2012-09
- Volume
- 19
- Issue
- 1_suppl
- Pages
- 42-56
- ISSN
- 0969-1413 (ISSN-L)
- 1475-5793
- OpenAlex
- W2137584842
- Cited by
- 407
- References
- 15
- FWCI
- 21.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.